Contact this trialFirst, we need to learn more about you.
Mechanisms of Post COVID-19 Tachycardia Syndrome
Recruiting1 award2 criteria
Nashville, Tennessee
This trial is testing if a drug can help with a condition called Long COVID, which is a disabling syndrome that persists beyond the 3-month convalescence period after COVID-19 infections.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.